openPR Logo
Press release

Mitotic Inhibitors Market Top Industry Players, Revenue By 2025

02-23-2018 10:06 AM CET | Health & Medicine

Press release from: Transparency Market Research

Mitotic Inhibitors Market Top Industry Players, Revenue By 2025

Mitosis is a process of cell division, wherein a cell divides into an identical cell through multiplication and separation of its chromosomes. The separation of chromosomes is carried out by microtubules in the cell. Mitotic inhibitors are substances that inhibit the separation of chromosomes by binding to tubulin, which are the building blocks of microtubules. Mitotic inhibitors are naturally derived products from various plant extracts. Mitotic inhibitors are widely used in the life sciences and medical industries. Mitotic inhibitor drugs are used to treat various types of cancer using chemotherapy. These drugs are targeted at cancer cells to stop multiplication and help eradicate cancer.

Mitotic inhibitors are widely used in life sciences for various studies such as study of chromosomes (cytogenetic). Several industry players are investing in the development and commercialization of mitotic inhibitor drugs to treat cancer and other medical conditions. Natural occurrence and efficiency in treating cancer are likely to increase the uptake of these drugs during the forecast period. Besides treating cancer, mitotic inhibitors have applications in antibiotics to control fungal infection and some are found to be useful in treating gout. Investments are being made to expand applications of mitotic inhibitors in the health care industry. However, several side effects are associated with the use of mitotic inhibitor drugs in cancer treatment, including nerve damage, muscle and joint pain, and nausea & vomiting. This in turn is anticipated to limit their use, thereby hampering market growth.



Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34148



The Global Mitotic Inhibitors Market can be segmented based on product type, application, end-user, and region. In terms of product type, the market can be divided into taxanes, vinca alkaloids, colchicine, podophyllotoxins, and others. The taxanes and vinca alkaloids segments are anticipated to account for significant shares of the global mitotic inhibitors market and are likely to experience strong growth during the forecast period from 2017 to 2025. Availability of large number of cancer drugs is expected to augment these segments. Based on application, the global mitotic inhibitors market can be segmented into therapeutics and life sciences. High consumption and high cost of therapeutic mitotic inhibitors are anticipated to drive the therapeutics segment during the forecast period. Based on end-user, the market can be classified into hospitals, ambulatory surgical centers, academic research institutes, and others.



Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34148



Geographically, the global mitotic inhibitors market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to constitute a large share of the global market during the forecast period, owing to high consumption of these drugs for cancer treatment. Moreover, high usage of mitotic inhibitors in life sciences in this region is projected to fuel the growth of the mitotic inhibitors market in North America during the forecast period from 2017 to 2025. Europe is anticipated to account for a significant share of the global market during the forecast period.

According to the World Health Organization, around 3.7 million new cancer cases are registered in Europe each year. Increase in health care expenditure in Asia Pacific is likely to propel the market during the forecast period. Furthermore, increasing investment in life sciences is projected to boost the growth of the mitotic inhibitors market in Asia Pacific.

Major players operating in the global mitotic inhibitors market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Eisai Co., Ltd., Bristol-Myers Squibb Company, Celgene Corporation, Novartis AG, Pharm US LLC, Merck KGaA, AdooQ BioScience, and Enzo Life Sciences, Inc., among others.



View Report -

https://www.transparencymarketresearch.com/mitotic-inhibitors-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mitotic Inhibitors Market Top Industry Players, Revenue By 2025 here

News-ID: 955038 • Views: 211

More Releases from Transparency Market Research

Water Purifier Market - Competitive Dynamics, Trends, Forecast 2027
Transparency Market Research delivers key insights on the global water purifier market. In terms of revenue, the global water purifier market is estimated to expand at a CAGR of ~ 9% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the water purifier market report. Browse Report Details: https://www.transparencymarketresearch.com/water-purifier-market-2017-2025.html Water purifiers help in removing bacterial contaminants and viruses from water and make it safe
Sheet Face Masks Market Leading Vendors: Sephora Inc. Boss Biological Technique …
The Sheet face masks market promises robust growth during 2018-2026, thanks to rising demand for sheet face mask products. Growing demand for personal hygiene products, and beautification products are expected to drive significant growth. The rising demand for natural ingredients in sheet face masks products is expected to emerge as the largest trend in the market. Browse Report Details: https://www.transparencymarketresearch.com/sheet-face-masks-market.html Sheet face masks are often associated with a certain prestige and rejuvenating
Global Nail Care Market to Reach US$ 20,940.2 Mn by 2027
According to a new research report published by Transparency Market Research titled ‘Nail Care Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027,’ the global nail care market is expected to reach a value of US$ 20,940.2 Mn by 2027, expanding at a CAGR of 8.4% from 2019 to 2027. In terms of volume, the market is expected to reach 1,494.2 Mn units by 2027, expanding at
Industrial Dispensing System and Equipment Market to Reach ~ US$ 16.7 Bn by 2027
Transparency Market Research delivers key insights on the global industrial dispensing system and equipment market. In terms of revenue, the global industrial dispensing system and equipment market is estimated to expand at a CAGR of ~ 6% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the industrial dispensing system and equipment market report. Browse Report Details: https://www.transparencymarketresearch.com/industrial-dispensing-system-equipment-market.html Industrial dispensing systems and equipment are

All 5 Releases


More Releases for Mitotic

Chemotherapy Market 2018 focuses on Top Most key Players - Eli Lilly & Company, …
A research study titled, “Chemotherapy Market by drugs, route of administration (intravenous and oral), indication and end user) - global industry analysis and forecast to 2023” published by crystal market research. Major Leading Players: The leading players in the market are Eli Lilly & Company, Novartis, GlaxoSmithKline, Boehringer Ingelheim and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial
Mitotic Inhibitors Market Size & Share, Forecast 2017-2025: Development Trends a …
The report analyzes and presents an overview of "Mitotic Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" worldwide. The main objective of this report is to define, describe, and forecast the global “Mitotic Inhibitors” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an analysis of the major factors influencing the growth of the
Global Paclitaxel Market by Manufacturers, Countries, Type and Application, Fore …
ReportsWorldwide has announced the addition of a new report title Global Paclitaxel Market by Manufacturers, Countries, Type and Application, Forecast to 2022 to its growing collection of premium market research reports. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew,
United States Breast Cancer Therapeutics Drugs Market: Industry Research and For …
This report studies sales (consumption) of Breast Cancer Therapeutics Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Bayer HealthCare Eli Lily Pfizer Novartis Eisai Halozyme Therapeutics Roche Puma Biotechnology Janssen Biotech AbbVie BioMarin Array BioPharma Merck Syndax MacroGenics Get sample Copy of this report@ http://www.researchtrades.com/request-sample/1050038 Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Mitotic Inhibitors Anti-metabolites Zoladex Aromatase Inhibitors HER2 Inhibitors Purchase copy
Global Breast Cancer Therapeutics Drugs Market: By Types - Mitotic Inhibitors, A …
Latest industry research report on: Global Breast Cancer Therapeutics Drugs Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Notes: Sales, means the sales volume of Breast Cancer Therapeutics Drugs Revenue, means the sales value of Breast Cancer Therapeutics Drugs Request For Sample Report @ http://www.marketresearchreports.biz/sample/sample/959704 This report studies sales (consumption) of Breast Cancer Therapeutics Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top
Higher Incidence and Rising Prevalence to Drive Breast Cancer Therapeutics Marke …
Breast Cancer Therapeutics Market – Global Breast Cancer Drug Classes Analysis and Forecast 2013-2020, estimates the global breast cancer therapeutics market to reach nearly USD 12.8 Billion in 2020, at a CAGR of 8.5% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Breast Cancer Therapeutics Market – Global Breast Cancer Drug Classes Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/breast-cancer-therapeutics-market/ Breast cancer therapeutics include hormone therapies, signal